0.4404
price down icon3.61%   -0.0165
after-market アフターアワーズ: .45 0.0096 +2.18%
loading

Sangamo Therapeutics Inc (SGMO) 最新ニュース

pulisher
Aug 10, 2025

Sangamo Therapeutics Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

Aug 10, 2025
pulisher
Aug 10, 2025

Healthcare Sector Analysts Weigh In on Sangamo Biosciences, Pliant Therapeutics, and Zimmer Biomet Holdings - AInvest

Aug 10, 2025
pulisher
Aug 08, 2025

Transcript : Sangamo Therapeutics, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Sangamo: Q2 Earnings Snapshot - Greenwich Time

Aug 08, 2025
pulisher
Aug 08, 2025

Earnings call transcript: Sangamo Therapeutics Q2 2025 earnings miss, stock drops - Investing.com Australia

Aug 08, 2025
pulisher
Aug 08, 2025

Sangamo Q2 2025 slides: Neurology pipeline advances amid financial challenges - Investing.com Australia

Aug 08, 2025
pulisher
Aug 08, 2025

Sangamo Therapeutics shares fall 4.55% premarket after Q2 revenue misses estimates. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Sangamo Therapeutics Inc (SGMO) Q2 2025 Earnings Call Highlights: Promising Fabry Disease ... By GuruFocus - Investing.com Canada

Aug 08, 2025
pulisher
Aug 08, 2025

Sangamo Therapeutics 2025 Q2 Earnings Improved Losses Despite Revenue Surge - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Sangamo Therapeutics Reports Strong Q2 2025 Results - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

Sangamo Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Sangamo Therapeutics (SGMO) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

Sangamo Therapeutics Q2 Misses Revenue Estimates and Reiterates 2025 Guidance — What This Means for Its Strategic Path Forward - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Sangamo Therapeutics earnings missed by $0.06, revenue fell short of estimates - Investing.com

Aug 07, 2025
pulisher
Aug 07, 2025

Sangamo Therapeutics Q2 revenue misses estimates - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results - Morningstar

Aug 07, 2025
pulisher
Aug 04, 2025

Sangamo Therapeutics Announces Second Quarter 2025 Earnings CallLife Science Industry News - Zenopa

Aug 04, 2025
pulisher
Aug 03, 2025

Is Sangamo Therapeutics Inc. stock overvalued or undervaluedHigh-yield market plays - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are Sangamo Therapeutics Inc. company’s key revenue driversBuild a diversified portfolio for steady growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Sangamo Therapeutics Inc. compare to its industry peersGet timely alerts on market opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Sangamo Therapeutics Inc. stock attracting strong analyst attentionGet daily updates on top-performing stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Sangamo Therapeutics Inc. stockRapid growth trajectories - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Sangamo Therapeutics Inc. stock perform well during market downturnsBuild wealth faster with consistent investment plans - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Is Sangamo Therapeutics Inc. a good long term investmentBuild a portfolio with strong long-term growth - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What makes Sangamo Therapeutics Inc. stock price move sharplyInvest smarter with daily market updates - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

When is Sangamo Therapeutics Inc. stock expected to show significant growthAccess powerful market insights for free - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What drives Sangamo Therapeutics Inc. stock priceInvest smarter with expert stock picks - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are the technical indicators suggesting about Sangamo Therapeutics Inc.Free Stock Index Interpretation - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

Sangamo Therapeutics Announces Q2 2025 Earnings Call and Webcast - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

How strong is Sangamo Therapeutics Inc. company’s balance sheetDaily Trading Strategy For Smart Trading - Jammu Links News

Aug 01, 2025
pulisher
Jul 30, 2025

Has Sangamo Therapeutics Inc. formed a bullish divergenceOversold Bounce Stock Play Ideas Gain Attention - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-30 16:12:38 - beatles.ru

Jul 30, 2025
pulisher
Jul 30, 2025

Will Sangamo Therapeutics Inc. outperform the marketAI Trading Suggestions With Accuracy Focus Released - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Hunter Syndrome Treatment Market Exclusive Report with - openPR.com

Jul 30, 2025
pulisher
Jul 28, 2025

How volatile is Sangamo Therapeutics Inc. stock compared to the marketAI Powered Updates From AI Tools - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Sangamo Therapeutics Inc. stockDiscover high-impact stocks for growth - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

What are the latest earnings results for Sangamo Therapeutics Inc.Free Stock Updates For 2025 - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-28 06:51:50 - Jammu Links News

Jul 27, 2025
pulisher
Jul 27, 2025

Why Sangamo Therapeutics Inc. stock is on top investor watchlistsSafe and Scalable Investment Tips - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 08:45:15 - metal.it

Jul 27, 2025
pulisher
Jul 26, 2025

How Sangamo Therapeutics Inc. stock performs during market volatilityChart Breakout Alert - metal.it

Jul 26, 2025
pulisher
Jul 26, 2025

Sangamo Therapeutics Announces Positive Phase 1/2 STAAR Study Results for Fabry Gene Therapy - MSN

Jul 26, 2025
$79.19
price up icon 1.02%
$36.19
price down icon 3.70%
$28.25
price down icon 1.43%
$112.89
price up icon 3.05%
$109.26
price down icon 2.15%
biotechnology ONC
$289.75
price up icon 0.54%
大文字化:     |  ボリューム (24 時間):